AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$621M |
| 2 |
Visa
V
|
+$574M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$542M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$525M |
| 5 |
Amazon
AMZN
|
+$441M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$693M |
| 2 |
Texas Instruments
TXN
|
+$477M |
| 3 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$235M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Healthcare | 14.87% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Financials | 12.61% |
| 5 | Communication Services | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Anterix
ATEX
$1.71B
| $370K | ﹤0.01% |
6,100
-700
| -10% | -$41K |
|
2877
GCM Grosvenor
GCMG
$749M
| $370K | ﹤0.01% |
+32,086
| New | +$348K |
|
2878
Retractable Technologies
RVP
$20.2M
| $370K | ﹤0.01% |
33,500
| – | – |
|
2879
SunPower Inc
SPWR
$67.2M
| $370K | ﹤0.01% |
38,077
| – | – |
|
2880
Kelly Services Class A
KELYA
$566M
| $368K | ﹤0.01% |
19,518
-7,200
| -27% | -$151K |
|
2881
BioAtla
BCAB
$5.54M
| $365K | ﹤0.01% |
248
-38
| -13% | -$74K |
|
2882
iShares Core S&P US Growth ETF
IUSG
$30.8B
| $365K | ﹤0.01% |
3,566
+1,312
| +58% | +$139K |
|
|
TRUE
2883
DELISTED
TrueCar
TRUE
| $365K | ﹤0.01% |
87,800
-18,100
| -17% | -$84K |
|
2884
First Community Bankshares
FCBC
$924M
| $363K | ﹤0.01% |
11,445
-900
| -7% | -$27.2K |
|
|
ICPT
2885
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $362K | ﹤0.01% |
24,370
-8,000
| -25% | -$128K |
|
2886
Bar Harbor Bankshares
BHB
$663M
| $361K | ﹤0.01% |
12,858
+2,500
| +24% | +$69.1K |
|
|
KE
2887
Kimball Electronics
KE
$584M
| $361K | ﹤0.01% |
14,000
-2,947
| -17% | -$67.3K |
|
|
BFS
2888
Saul Centers
BFS
$886M
| $360K | ﹤0.01% |
8,177
-670
| -8% | -$30.2K |
|
|
TRTX
2889
TPG RE Finance Trust
TRTX
$667M
| $360K | ﹤0.01% |
29,100
-2,200
| -7% | -$28.2K |
|
2890
Univest Financial
UVSP
$1.24B
| $359K | ﹤0.01% |
13,094
-938
| -7% | -$25.2K |
|
|
AKRO
2891
DELISTED
Akero Therapeutics
AKRO
| $358K | ﹤0.01% |
16,000
-2,900
| -15% | -$65.6K |
|
2892
Capital Southwest
CSWC
$1.47B
| $358K | ﹤0.01% |
14,222
-6,699
| -32% | -$174K |
|
|
UBA
2893
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $358K | ﹤0.01% |
18,893
-13,762
| -42% | -$263K |
|
|
FLXN
2894
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $357K | ﹤0.01% |
58,600
| – | – |
|
|
OSG
2895
Octave Specialty Group
OSG
$261M
| $356K | ﹤0.01% |
24,880
-4,150
| -14% | -$59.3K |
|
2896
Harmony Biosciences
HRMY
$2.09B
| $356K | ﹤0.01% |
9,300
-5,400
| -37% | -$174K |
|
|
GRTS
2897
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $356K | ﹤0.01% |
33,000
| – | – |
|
2898
Entravision Communication
EVC
$995M
| $354K | ﹤0.01% |
49,800
-2,600
| -5% | -$17.6K |
|
2899
Koppers
KOP
$966M
| $353K | ﹤0.01% |
11,283
-2,280
| -17% | -$71K |
|
2900
Phathom Pharmaceuticals
PHAT
$958M
| $353K | ﹤0.01% |
11,000
-1,300
| -11% | -$43.2K |
|
Similar funds
AllianceBernstein's Q3 2021 Portfolio in Review
As of Q3 2021, AllianceBernstein held 3,430 positions worth $253B, up 1.8% from $249B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
AllianceBernstein's Q3 2021 filing shows 114 new, 1,102 increased, 1,623 reduced and 152 closed positions. Its largest new stake was Freshworks: 2,094,708 shares worth $89.4M. The largest sale was Alphabet (Google) Class C, an estimated $693M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- AllianceBernstein's largest Q3 2021 buy was Freshworks: 2,094,708 shares worth $89.4M.
- AllianceBernstein added most to Qualcomm in Q3 2021, an estimated $621M increase.
- AllianceBernstein's biggest Q3 2021 reduction was Alphabet (Google) Class C, cutting an estimated $693M.
- AllianceBernstein fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $230M.
- AllianceBernstein's ten largest holdings make up 25% of its $253B portfolio in Q3 2021.
- AllianceBernstein opened 114 new positions and closed 152 in Q3 2021.
- AllianceBernstein's portfolio value rose 1.8% quarter-over-quarter to $253B.
Based on AllianceBernstein's 13F filing for Q3 2021, filed 10 Nov 2021.